In 2004, Purdue Pharma was facing a threat to sales of its blockbuster opioid painkiller OxyContin, which were approaching $2 billion a year. With abuse of the drug ...

As Sanofi Genzyme and Regeneron continue to add indications for their next-gen immunology treatment Dupixent, the partners have created a separate unbranded cam...

Novartis' Entresto, the clear-cut market leader in heart failure, has been soul-searching since its highly touted trial in an untreated population fell flat. No...

Leo Pharma wants to destigmatize psoriasis. Its latest awareness campaign for the autoimmune skin condition will use videos, animations and infographics to try ...

In August, Torrent Pharmaceuticals recalled dozens of lots of over-the-counter cough syrups, nasal sprays and rectal suppositories that put children and adults at ri...

ꟷ    Arabkir Joint Medical Center & Institute of Child and Adolescent Health gains visibility for participation in international clinical stu...

A protein that drives growth of pancreatic cancer, and which could be a target for new treatments, has been identified by researchers at the Crick. The study, publi...

After years in development and outbreaks that have claimed thousands of lives, the world has its first licensed Ebola vaccine. Merck’s Ervebo&nbs...

A host of generic drug makers recently recalled their generic Zantac from the U.S. market after the FDA raised concerns about how much of an expected carcinogen was ...

Bayer’s new corporate campaign—the largest in its history—turns science into a verb. The effort, “Why We Science,” launched recently with a series of TV ads along wi...